Balance Sheet

Assets

+18%

+4%

10Y

Currency: KRW

	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	260	443	333	1 079	914	2 161	1 737	3 250	5 086	1 977	4 363	3 815	5 808	8 703	5 472	10 035	5 624	8 794	7 430	7 430	8 751	10 279
Cash Equivalents	260	443	333	1 079	914	2 161	1 737	3 250	5 086	1 977	4 363	3 815	5 808	8 703	5 472	10 035	5 624	8 794	7 430	7 430	8 751	10 279
Short-Term Investments	1 319	1 208	1 005	6 513	4 953	4 477	6 331	4 441	4 227	3 897	5 475	5 658	5 680	4 595	8 970	17 320	19 415	15 343	6 860	5 360	10 265	11 125
Total Receivables	2 354	1 336	1 587	2 361	2 787	3 298	2 654	3 304	8 089	7 729	9 160	8 654	9 060	8 584	8 850	9 029	7 912	6 899	10 371	14 302	11 818	14 053
Accounts Receivables	2 211	1 309	1 528	2 320	2 626	3 138	2 605	3 251	7 885	7 578	8 987	8 528	9 018	8 559	8 666	8 807	7 751	6 716	10 249	14 151	11 739	13 553
Other Receivables	143	27	59	41	161	160	49	53	204	151	173	126	42	25	184	222	161	183	122	151	80	500
Inventory	721	997	1 120	811	1 374	2 406	2 111	2 534	5 640	7 318	5 707	6 099	5 445	5 916	7 541	8 345	10 739	10 441	13 676	15 452	14 802	17 041
Other Current Assets	26	179	263	137	242	93	167	113	236	303	282	427	664	108	139	3 402	172	3 993	3 839	3 725	3 646	3 338
Total Current Assets	4 679	4 163	4 307	10 899	10 269	12 435	13 001	13 641	23 278	21 224	24 987	24 653	26 657	27 905	30 971	48 131	43 862	45 470	42 175	46 269	49 281	55 836
PP&E Net	3 513	3 661	4 040	4 973	4 697	4 110	14 552	13 876	20 135	21 416	20 334	19 824	20 026	20 101	18 347	17 930	18 769	12 910	14 900	14 615	14 159	13 924
PP&E Gross	3 513	3 661	4 040	4 973	4 697	4 110	14 552	13 876	20 135	21 416	20 334	19 824	20 026	20 101	18 347	17 930	18 769	12 910	14 900	14 615	14 159	13 924
Accumulated Depreciation	626	979	1 304	1 774	2 348	2 952	4 416	4 332	7 595	8 608	9 680	10 957	12 010	12 618	13 024	14 761	16 455	7 899	8 881	9 886	10 954	11 885
Intangible Assets	336	281	228	175	128	78	31	187	351	345	342	344	297	298	302	271	304	199	199	398	632	649
Goodwill	0	0	0	0	0	0	0	0	590	590	590	590	590	590	590	590	590	590	590	590	0	0
Note Receivable	127	45	54	894	1 818	2 631	744	940	998	915	804	722	663	557	606	737	917	777	576	523	507	436
Long-Term Investments	537	2	137	2	1 875	1 639	626	685	657	804	916	788	592	9 456	8 314	4 638	3 105	1 238	866	482	716	637
Other Long-Term Assets	492	464	233	296	400	403	406	289	260	482	379	422	386	251	414	330	386	901	1 062	1 165	721	506
Other Assets	0	0	0	0	0	0	0	0	590	590	590	590	590	590	590	590	590	590	590	590	0	0
Total Assets	9 683 N/A	8 614 -11%	8 999 +4%	17 239 +92%	19 187 +11%	21 296 +11%	29 360 +38%	29 618 +1%	46 269 +56%	45 776 -1%	48 351 +6%	47 343 -2%	49 211 +4%	59 157 +20%	59 543 +1%	72 627 +22%	67 933 -6%	62 085 -9%	60 368 -3%	64 041 +6%	66 017 +3%	71 988 +9%
Liabilities
Accounts Payable	2 025	1 156	300	215	243	1 512	295	430	3 141	2 043	2 488	3 152	3 708	4 235	3 693	3 547	2 709	1 671	4 752	3 901	3 540	3 366
Accrued Liabilities	42	62	62	35	36	36	88	94	198	342	352	379	359	387	456	524	839	532	516	649	970	1 077
Short-Term Debt	350	200	0	0	0	1 500	0	0	6 863	5 805	5 390	5 079	3 271	3 312	4 816	3 971	2 738	4 352	8 042	9 486	7 704	10 851
Current Portion of Long-Term Debt	205	775	1 020	478	0	0	300	626	166	966	42	1 531	300	0	0	0	80	5 455	112	1 201	1 667	2 454
Other Current Liabilities	952	299	577	841	1 164	586	912	998	1 113	1 255	1 050	2 872	3 216	3 600	3 280	5 988	3 576	1 056	716	682	632	616
Total Current Liabilities	3 574	2 492	1 960	1 569	1 443	3 635	1 594	2 147	11 482	10 411	9 321	13 012	10 854	11 535	12 246	14 030	9 942	13 065	14 139	15 920	14 513	18 364
Long-Term Debt	1 864	1 244	699	0	0	300	9 097	8 273	13 734	11 984	13 411	10 393	11 278	8 744	7 752	12 624	14 506	1 182	2 147	2 342	3 130	2 580
Deferred Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	1 868	1 481	577	56	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	106	376	628	1 022	9	976	2 210	2 487	2 433	2 657	3 598	0	0	0	0	0
Other Liabilities	82	162	220	234	167	50	587	888	1 573	2 107	2 519	517	452	475	9	89	98	2 795	137	53	69	72
Total Liabilities	5 520 N/A	3 898 -29%	2 879 -26%	1 803 -37%	1 609 -11%	3 985 +148%	11 384 +186%	10 931 -4%	26 161 +139%	25 524 -2%	25 261 -1%	22 946 -9%	20 374 -11%	20 135 -1%	19 054 -5%	24 664 +29%	21 004 -15%	17 042 -19%	16 423 -4%	18 315 +12%	17 712 -3%	21 016 +19%
Equity
Common Stock	2 110	2 110	2 110	3 065	3 065	3 065	3 065	3 065	3 065	3 065	3 398	3 508	4 174	4 305	4 305	4 305	4 305	4 305	4 305	4 305	4 305	4 305
Retained Earnings	1 297	1 850	3 250	5 158	7 320	7 328	7 894	9 007	9 420	9 641	9 727	10 571	12 058	14 444	16 556	18 698	19 303	16 844	16 190	18 116	29 059	31 803
Additional Paid In Capital	695	695	695	7 206	7 206	7 206	7 206	7 206	8 228	8 193	9 994	10 387	12 779	13 646	13 646	14 800	14 800	14 835	14 489	14 576	14 576	14 576
Unrealized Security Profit/Loss	0	0	3	7	0	308	0	0	0	0	0	0	0	6 877	5 940	10 212	8 639	9 059	8 961	8 729	364	288
Treasury Stock	0	0	0	0	0	596	596	596	596	596	0	0	0	0	0	0	0	0	0	0	0	0
Other Equity	61	61	61	0	14	0	407	5	9	52	30	70	174	250	41	51	118	0	0	0	0	0
Total Equity	4 163 N/A	4 716 +13%	6 120 +30%	15 436 +152%	17 577 +14%	17 311 -2%	17 976 +4%	18 687 +4%	20 109 +8%	20 251 +1%	23 090 +14%	24 397 +6%	28 836 +18%	39 022 +35%	40 489 +4%	47 963 +18%	46 929 -2%	45 043 -4%	43 945 -2%	45 726 +4%	48 305 +6%	50 972 +6%
Total Liabilities & Equity	9 683 N/A	8 614 -11%	8 999 +4%	17 239 +92%	19 187 +11%	21 296 +11%	29 360 +38%	29 618 +1%	46 269 +56%	45 776 -1%	48 351 +6%	47 343 -2%	49 211 +4%	59 157 +20%	59 543 +1%	72 627 +22%	67 933 -6%	62 085 -9%	60 368 -3%	64 041 +6%	66 017 +3%	71 988 +9%
Shares Outstanding
Common Shares Outstanding	4	4	4	6	6	6	6	6	6	6	7	7	8	9	9	9	9	9	9	9	9	9

Income Statement Balance Sheet Cash Flow Statement

GeneBioTech Co Ltd
KOSDAQ:086060

Balance Sheet

Balance Sheet Decomposition
GeneBioTech Co Ltd

Balance Sheet
GeneBioTech Co Ltd

See Also

Company

Help

Tools

Stocks

GeneBioTech Co Ltd KOSDAQ:086060

Balance Sheet

Balance Sheet Decomposition GeneBioTech Co Ltd

Balance Sheet GeneBioTech Co Ltd

See Also

Company

Help

Tools

Stocks

GeneBioTech Co Ltd
KOSDAQ:086060

Balance Sheet Decomposition
GeneBioTech Co Ltd

Balance Sheet
GeneBioTech Co Ltd